What Is a Low Attenuation Lesion on the Kidney?

A low attenuation lesion on the kidney is an area that appears darker than surrounding kidney tissue on a CT scan, meaning it absorbs fewer X-rays. In the vast majority of cases, this finding turns out to be a simple fluid-filled cyst, which is harmless and needs no treatment. But “low attenuation” is a description, not a diagnosis. While most of these spots are benign, a small percentage turn out to be something that warrants closer attention, from complex cysts to early-stage tumors to infections.

What “Low Attenuation” Actually Means on a CT Scan

CT scanners measure how much different tissues absorb X-rays, and they report this on a scale called Hounsfield units (HU). Water sits at 0 HU, air at roughly −1000 HU, and dense bone well above 1000 HU. Normal kidney tissue on an unenhanced scan usually measures somewhere in the 20–40 HU range. When radiologists call something “low attenuation,” they mean it measures noticeably lower than the surrounding kidney, usually in the range you would expect for fluid (close to 0 HU) or at least well below normal tissue.

The practical cutoff that matters most is around 20 HU. A lesion measuring 20 HU or less on an unenhanced scan that does not pick up contrast dye is, in most protocols, presumed to be a simple cyst. Lesions between about 20 and 70 HU on an unenhanced scan fall into an indeterminate zone where further evaluation is usually recommended. One large study of patients who had unenhanced CT scans found that roughly one in seven people had at least one kidney mass; of those, about 87% were classified as benign using attenuation criteria, while roughly 13% fell into an indeterminate category needing follow-up.¹

Simple Cysts Are by Far the Most Common Explanation

The overwhelming majority of low attenuation kidney findings are simple cysts. These are thin-walled, fluid-filled sacs that form within the kidney tissue. They are extremely common, especially as people age, and they carry essentially zero risk of becoming cancer. On a CT scan, a simple cyst typically measures close to water density (0–20 HU), has smooth thin walls, shows no internal solid components, and does not enhance after contrast dye is injected.²

If your radiology report describes a “simple-appearing cyst” or a “Bosniak I” lesion, this is what they mean. These require no treatment and usually no follow-up imaging. Many people have multiple cysts across both kidneys and never experience symptoms or complications from them.

When the Lesion Is Not Clearly a Simple Cyst

The picture gets more complicated when a low attenuation lesion does not tick every box for a simple cyst. It might have slightly thicker walls, thin internal divisions (called septa), a tiny calcification, or a density reading that is higher than water but lower than solid tissue. These are sometimes called “complex cysts,” and radiologists use a grading system called the Bosniak classification to sort them by their risk of being cancerous.

The Bosniak system underwent a major update in 2019. The revised version defines clearer imaging criteria and, importantly, incorporates MRI alongside CT. It also aims to move more lesions into lower-risk categories, reducing the number of benign cysts that get unnecessarily biopsied or treated.³ The updated system applies specifically to cystic masses where less than about a quarter of the lesion is enhancing solid tissue.⁴

In practical terms, the Bosniak system runs from class I (definitely benign, no follow-up needed) through class IV (strongly suspicious for cancer, usually treated surgically). The middle categories, IIF and III, are where most of the clinical uncertainty lives. A Bosniak IIF lesion is probably benign but gets periodic imaging follow-up. A Bosniak III lesion has roughly even odds and often prompts either biopsy or surgical removal. Your doctor’s recommendation will depend heavily on which Bosniak category your lesion falls into, along with your age, overall health, and other factors.

Solid Tumors That Mimic Cysts

Here is where things get genuinely tricky. Certain kidney cancers can measure in the low attenuation range on an unenhanced CT scan, overlapping with the numbers you would expect from a benign cyst. One type that frequently does this is papillary renal cell carcinoma. A study of confirmed papillary kidney cancers found that about one in five measured below 20 HU on unenhanced scans, and more than 60% measured below 30 HU. A small fraction even dipped below 10 HU, well into the range normally associated with fluid-filled cysts.⁵

Clear cell renal cell carcinoma, the most common subtype, typically measures higher on unenhanced scans. But even among clear cell tumors, a small number have been documented with attenuation values in the range of water, from about 11 to 19 HU.⁶ These are uncommon, but they illustrate why radiologists do not rely solely on an unenhanced scan to make a final call. The key distinguishing test is whether the lesion enhances, meaning it lights up after contrast dye is injected. A simple cyst does not enhance. A solid tumor, even a low-density one, virtually always does.

Fat-Containing Lesions and Angiomyolipoma

Not every low attenuation finding is fluid. Some kidney masses contain fat, which also appears dark on CT because fat has negative Hounsfield units. The classic example is an angiomyolipoma, a benign tumor made up of blood vessels, smooth muscle, and fat. When it contains enough fat, it is easy to identify: radiologists look for areas that measure well below 0 HU, in the range of fatty tissue.

The challenge is the “minimal fat” angiomyolipoma. These tumors have so little fat that they do not clearly show the telltale negative HU values. Research has shown that finding a small number of very low-density pixels within a mass (below −20 or −30 HU) can point toward angiomyolipoma with strong confidence, but most minimal-fat angiomyolipomas cannot be reliably distinguished from kidney cancers on CT alone.⁷ Machine learning tools trained on CT image features are being developed to help with this specific problem and have shown promising accuracy in research settings.⁸

Infections and Blocked Blood Flow

Low attenuation areas on a kidney CT do not always represent a mass or cyst. Infections and vascular problems can create similar-looking dark patches. In pyelonephritis, a bacterial kidney infection, CT can show wedge-shaped or patchy areas of reduced density within the kidney, representing inflamed tissue that is not enhancing normally. CT is considered a go-to imaging tool for evaluating the severity of pyelonephritis and its complications, including abscess formation.⁹ The clinical picture, including fever, flank pain, and abnormal urine tests, usually makes the distinction clear, but on a scan done for an unrelated reason, these areas can briefly puzzle the radiologist.

A renal infarction, where blood supply to part of the kidney is cut off, also produces a region of low attenuation on contrast-enhanced CT. The affected tissue does not receive the contrast dye, so it appears dark compared to the normally perfused kidney around it. A characteristic finding is a bright rim of tissue at the kidney’s surface surrounding a darker core, sometimes called the “CT rim sign.”¹⁰ This occurs because the outer rim of kidney tissue receives blood from a separate supply (the capsular arteries) and stays alive even when the main supply is interrupted.

The Pseudoenhancement Trap

One of the more frustrating aspects of kidney CT is an artifact called pseudoenhancement. This is when a lesion that is genuinely a harmless simple cyst appears to have slightly elevated attenuation numbers on a contrast-enhanced scan, making it look as though it has enhanced and therefore might be something more worrisome.

Pseudoenhancement is a real, measurable phenomenon that occurs with all CT scanner types. It results from the way scanners process X-ray beams passing through dense, contrast-filled tissue adjacent to a low-density cyst. Studies using phantom models found pseudoenhancement in about 38% of measurements of cysts sitting inside the kidney, with values sometimes climbing above 10 HU and occasionally approaching 28 HU.¹¹ Cysts located on the kidney’s outer surface (exophytic cysts) were essentially unaffected.

Small cysts and cysts sitting deep within the center of the kidney are the most vulnerable to this effect. Research found that lesions smaller than 10 mm were about six times more likely to show pseudoenhancement than larger lesions, and centrally located cysts were nearly three times more likely to be affected than peripheral ones.¹² When radiologists are aware of this pitfall, they can adjust their interpretation and avoid sending a patient for unnecessary workup over a perfectly innocent cyst that is just measuring a few HU higher than it should.

What Happens After Your Scan

If a low attenuation kidney lesion is found on your scan, the next steps depend on how confidently the radiologist can characterize it. The American College of Radiology (ACR) has published a detailed set of flowcharts for managing incidentally discovered kidney masses on CT, outlining when additional imaging, surveillance, or referral for treatment is appropriate.¹³

In the study mentioned earlier of patients with incidental kidney masses, four out of 41 people whose lesions were categorized as indeterminate were eventually diagnosed with kidney cancer over a follow-up period averaging about four and a half years. The classification system used in the study achieved 100% sensitivity for catching those cancers, meaning it did not miss any, with about 89% specificity, meaning it correctly reassured most of the people who did not have cancer.¹

For small kidney masses (generally under about 4 cm), the management landscape has shifted considerably. About one in five of these small masses turns out to be benign, and many of the malignant ones grow slowly and have relatively nonaggressive features. Active surveillance, meaning regular imaging to monitor for growth, has become an accepted strategy, especially for older patients or those with significant health conditions where surgery would carry higher risk.¹⁴ Percutaneous biopsy, where a needle is guided into the mass through the skin, is also increasingly used to guide decisions rather than moving straight to surgery.

When Your Doctor Orders More Imaging

If CT alone cannot definitively categorize a low attenuation lesion, MRI is often the next step. MRI excels at detecting subtle enhancement in kidney masses, particularly those that are already bright on baseline unenhanced images, where the contrast uptake can be hard to judge on CT. Image subtraction techniques, where a pre-contrast MRI image is digitally subtracted from a post-contrast image, allow radiologists to see enhancement with high accuracy.¹⁵

Contrast-enhanced ultrasound (CEUS) is another tool gaining traction, particularly for cystic lesions and for patients who cannot receive CT contrast dye due to kidney impairment or allergies. CEUS uses microbubble contrast agents that are purely intravascular and are cleared through the lungs and liver rather than the kidneys. It has exceptional sensitivity for detecting even minimal blood flow within a lesion. Studies report that CEUS has a negative predictive value approaching 100% for ruling out vascular perfusion, meaning that if CEUS shows no blood flow in a lesion, you can be very confident it is a benign cyst.¹⁶ CEUS also performs well in detecting enhancement in thin septa and tiny nodules, making it particularly useful for monitoring complex cystic masses over time.¹⁷

A cost-effectiveness analysis comparing these imaging modalities for monitoring complex cystic kidney lesions found that CEUS was actually less expensive and produced better outcomes than standard contrast-enhanced CT, while MRI was more effective but substantially more expensive.¹⁸ CEUS does not involve radiation exposure, which matters when repeated follow-up scans are needed over years.

How the Finding Differs in Children

The discussion above applies mainly to adults, where simple cysts and renal cell carcinoma dominate the differential diagnosis. In children, the landscape is different. Simple kidney cysts are far less common in pediatric patients, and when a kidney mass is found, the range of possibilities shifts. Wilms tumor is the most common pediatric kidney cancer, and it has distinct imaging features, including a tendency to invade blood vessels and displace surrounding structures. Other childhood kidney masses include mesoblastic nephroma, which is the primary consideration in a newborn with a solid kidney mass, and multilocular cystic renal tumor, suggested by a large mass with many cysts and little solid tissue.¹⁹ Renal cell carcinoma, the most common adult type, is unusual in children and tends to appear in the second decade of life.

Machine Learning and the Future of Kidney Mass Characterization

Researchers are training machine learning algorithms to analyze CT texture features that the human eye cannot easily distinguish, with the goal of classifying kidney masses more accurately from imaging alone. One study applied multiple algorithms to contrast-enhanced CT images of solid kidney masses and found that a random forest model achieved about 91% accuracy in separating benign from malignant masses.²⁰ Similar approaches are being tested on cystic masses, where algorithms extract features like statistical patterns in pixel brightness to classify lesions.²¹

These tools are still in the research and validation phase, not in routine clinical use. But the direction they point in is clear: imaging reports of the future may include algorithmically generated probability estimates alongside the radiologist’s visual assessment, giving doctors more data to decide which low attenuation lesions need biopsy and which can safely be left alone.

Coping With the Report Before Your Appointment

Finding the phrase “low attenuation lesion” on a radiology report before you have had a chance to talk with your doctor can be alarming. Research into how patients perceive incidental kidney findings confirms that people often overestimate the risk of cancer when they receive this kind of result. A randomized study found that providing patients with clear numerical and graphical information about the actual risk helped them form more accurate expectations and make more informed decisions about follow-up.²²

The most grounding statistic is the one from the beginning of this article: in large screening-style studies, roughly 87% of incidentally found kidney masses are clearly benign by imaging criteria alone. Among those that do need further evaluation, the majority still turn out to be harmless. Kidney cancer is a possibility, but it is the exception, not the rule, for an incidental low attenuation finding. Your radiologist and urologist are trained to sort these out efficiently, and for many people, the outcome is a clean bill of health and perhaps a note to repeat imaging in six months or a year just to confirm nothing has changed.